Impact of Roux-en-Y Gastric Bypass Limb Length on HbA1c Levels in Obese Individuals with Type 2 Diabetes - Summary - MDSpire

Impact of Roux-en-Y Gastric Bypass Limb Length on HbA1c Levels in Obese Individuals with Type 2 Diabetes

  • By

  • Lena Seidemann

  • Roland Morgenroth

  • Yusef Moulla

  • Undine Gabriele Lange

  • Orestis Lyros

  • Matthias Blüher

  • David Petroff

  • Christiane Prettin

  • Norbert Köhler

  • Arne Dietrich

  • April 21, 2026

  • 0 min

Share

Objective:

To compare the efficacy of Roux-en-Y gastric bypass (RYGB) with long alimentary limb (AL) versus long biliopancreatic limb (BPL) on HbA1c levels in obese individuals with type 2 diabetes (T2D), focusing on primary and secondary endpoints.

Key Findings:
  • The study aimed to assess the impact of limb length on HbA1c levels at 12 months post-surgery, with specific data to be included.
  • Longer BPL was hypothesized to improve T2D outcomes compared to longer AL, with expected results to be detailed.
Interpretation:

The findings may provide insights into optimizing RYGB techniques for better T2D management in obese patients.

Limitations:
  • Insufficient recruitment and high dropout rates in the non-surgical arm limited randomization, potentially biasing results.
  • The study was conducted at a single center, which may affect generalizability; further context on this limitation is needed.
Conclusion:

The study aims to clarify the relationship between RYGB limb lengths and T2D outcomes, potentially guiding surgical practices based on specific findings.

Original Source(s)

Related Content